CHERYL WHITE-DAVIS: Open Payments
NPI 1922016138 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 62 payments from 12 companies in 2025. Trend: 2023 $513 · 2024 $3,703 · 2025 $908
Food & beverage: $865Education: $43
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $288 |
| ABBVIE INC. | 23 | $273 |
| Incyte Corporation | 4 | $79 |
| GENZYME CORPORATION | 3 | $58 |
| Janssen Biotech, Inc. | 2 | $57 |
| UCB, Inc. | 2 | $33 |
| Organon LLC | 4 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $17 |
Products named: OTEZLA, SKYRIZI, DUPIXENT, OPZELURA, RINVOQ, TREMFYA, Bimzelx, VTAMA.
Industry payments across NY — which companies pay providers there.
